Home
> Is This Safe When Breastfeeding?
> Medications
Lactation Risk Categories
source: Medications
and Mothers' Milk (2004) by Thomas W. Hale, PhD
| L1 |
SAFEST:
Drug which has been taken by a large number of breastfeeding
mothers without any observed increase in adverse effects in
the infant. Controlled studies in breastfeeding women fail to
demonstrate a risk to the infant and the possibility of harm
to the breastfeeding infant is remote; or the product is not
orally bioavailable in an infant.
|
| L2 |
SAFER:
Drug which has been studied in a limited number of breastfeeding
women without an increase in adverse effects in the infant;
And/or, the evidence of a demonstrated risk which is likely
to follow use of this medication in a breastfeeding woman is
remote.
|
| L3 |
MODERATELY
SAFE:
There are no controlled studies in breastfeeding women, however
the risk of untoward effects to a breastfed infant is possible;
or, controlled studies show only minimal non-threatening adverse
effects. Drugs should be given only if the potential benefit
justifies the potential risk to the infant.
|
| L4 |
POSSIBLY
HAZARDOUS:
There is positive evidence of risk to a breastfed infant or
to breastmilk production, but the benefits of use in breastfeeding
mothers may be acceptable despite the risk to the infant (e.g.
if the drug is needed in a life-threatening situation or for
a serious disease for which safer drugs cannot be used or are
ineffective).
|
| L5 |
CONTRAINDICATED:
Studies in breastfeeding mothers have demonstrated that there
is significant and documented risk to the infant based on human
experience, or it is a medication that has a high risk of causing
significant damage to an infant. The risk of using the drug
in breastfeeding women clearly outweighs any possible benefit
from breastfeeding. The drug is contraindicated in women who
are breastfeeding an infant. |
Additional information
Mechanisms
of Drug Entry into Human Milk by Thomas Hale, PhD
Medications and Breastfeeding:
References @
Page last modified:
09/08/2005
Added to website: 2/13/03